Technical Analysis for CNAT - Conatus Pharmaceuticals Inc.
|Grade||Last Price||% Change||Price Change|
CNAT closed up 2.48 percent on Tuesday, June 19, 2018, on 62 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
|See historical CNAT trend table...|
|Date||Alert Name||Type||% Chg|
|Jun 19||Calm After Storm||Range Contraction||0.00%|
|Jun 19||Upper Bollinger Band Walk||Strength||0.00%|
|Jun 19||Inside Day||Range Contraction||0.00%|
|Jun 19||Wide Bands||Range Expansion||0.00%|
|Jun 19||Overbought Stochastic||Strength||0.00%|
|Jun 18||Bearish Engulfing||Bearish||2.48%|
|Jun 18||Upper Bollinger Band Walk||Strength||2.48%|
|Jun 18||Wide Bands||Range Expansion||2.48%|
|Jun 18||Overbought Stochastic||Strength||2.48%|
|Jun 18||Upper Bollinger Band Touch||Strength||2.48%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of medicines to treat liver diseases in the United States. Its products include Emricasan, an orally active caspase protease inhibitor for the treatment of acute-on-chronic liver failure and chronic liver failure, as well as for the patients who have developed liver fibrosis post-orthotopic liver transplant due to Hepatitis C virus infection. The company was founded in 2005 and is headquartered in San Diego, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more CNAT news...
|52 Week High||7.95|
|52 Week Low||3.22|
|200-Day Moving Average||4.8487|
|50-Day Moving Average||3.9854|
|20-Day Moving Average||4.4545|
|10-Day Moving Average||4.942|
|Average True Range||0.3345|
|Chandelier Exit (Long, 3 ATRs )||4.5865|
|Chandelier Exit (Short, 3 ATRs )||4.6035|
|Upper Bollinger Band||5.6487|
|Lower Bollinger Band||3.2603|
|Percent B (%b)||0.88|
|MACD Signal Line||0.2527|
|Market Cap||161.12 Million|
|Num Shares||30 Million|
|Price-to-Earnings (P/E) Ratio||-5.48|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||5.72|
|Resistance 3 (R3)||5.68||5.53||5.66|
|Resistance 2 (R2)||5.53||5.44||5.55||5.64|
|Resistance 1 (R1)||5.45||5.39||5.49||5.49||5.62|
|Support 1 (S1)||5.22||5.21||5.26||5.26||5.12|
|Support 2 (S2)||5.07||5.16||5.09||5.10|
|Support 3 (S3)||4.99||5.07||5.08|
|Support 4 (S4)||5.03|